The Latest Breaking News from Novavax

It's a major turnaround for a drug company that warned last year about its ability to stay in business.

French pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines with a flu shot.

Exclusive: Multi-dose vials could push up charge per patient, with experts warning cost could widen inequalities

Concerns that some groups who are more at risk from virus face hefty price tag, as Boots set to charge almost £100 a shot

Pharmadoctor is offering appointments from 1 April for vaccinations and intends to add more pharmacies to its network

Would-be Tesla rivals VinFast and Fisker are among the most-shorted stocks. So are C3.ai and Upstart, which are big stock winners in 2023.

Vaccine uses different technology than Moderna and Pfizer's mRNA targeting strategy

The Food and Drug Administration signed off on Novavax's updated Covid booster late Tuesday, and NVAX stock surged just before the close.

U.S. regulators have added another option for fall COVID-19 vaccination, updated shots made by Novavax

WHO recommends R21/Matrix-M malaria vaccine developed by Oxford and Serum Institute of India. Vaccine has met safety, quality and effectiveness standards. Serum Institute has established production capacity for 100 million doses/annum. Vaccine efficacy over 12 months is 75% at sites with high seasonal malaria transmission and 68% at sites with…

All Americans ages 6 months and older are eligible for the new jabs, the CDC said Tuesday.